Background Previous studies investigating the association between TGF-β1 polymorphisms and Radiation Pneumonia (RP) risk have provided inconsistent results. The aim of our study was to assess the association between the TGF-β1 genes C509T, G915C and T869C polymorphisms and risk of RP in lung cancer patients treated with definitive radiotherapy. Methods Two investigators independently searched the Medline, Embase, CNKI, and Chinese Biomedicine Databases for studies published before September 2013. Summary odds ratios (ORs) and 95% confidence intervals (CIs) for TGF-β1 polymorphisms and RP were calculated in a fixed-effects model or a random-effects model when appropriate. Results Ultimately, each 7 studies were found to be eligible for meta-analyses of C509T, G915C and T869C, respectively. Our analysis suggested that the variant genotypes of T869C were associated with a significantly increased RP risk in dominant model (OR = 0.59, 95% CI = 0.45–0.79) and CT vs. TT model (OR = 0.47, 95% CI = 0.32–0.69). In the subgroup analyses by ethnicity/country, a significantly increased risk was observed among Caucasians. For C509T and G915C polymorphism, no obvious associations were found for all genetic models. Conclusion This meta-analysis suggests that T869C polymorphism of TGF-β1 may be associated with RP risk only in Caucasians, and there may be no association between C509T and G915C polymorphism and RP risk.
References
[1]
Alsbeih G, Story MD, Maor MH, Geara FB, Brock WA (2003) Chromosomal fragility syndrome and family history of radiosensitivity as indicators for radiotherapy dose modification. Radiother Oncol 66: 341–344. doi: 10.1016/s0167-8140(02)00327-4
[2]
Andreassen CN (2005) Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles? Acta Oncol 44: 801–815. doi: 10.1080/02841860500374513
[3]
Burger A, Loffler H, Bamberg M, Rodemann HP (1998) Molecular and cellular basis of radiation fibrosis. Int J Radiat Biol 73: 401–408. doi: 10.1080/095530098142239
[4]
Hakenjos L, Bamberg M, Rodemann HP (2000) TGF-beta1-mediated alterations of rat lung fibroblast differentiation resulting in the radiation-induced fibrotic phenotype. Int J Radiat Biol 76: 503–509. doi: 10.1080/095530000138501
[5]
Kong FM, Ao X, Wang L, Lawrence TS (2008) The use of blood biomarkers to predict radiation lung toxicity: a potential strategy to individualize thoracic radiation therapy. Cancer Control 15: 140–150.
[6]
Zhao L, Wang L, Ji W, Wang X, Zhu X, et al. (2009) Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan. Int J Radiat Oncol Biol Phys 74: 1385–1390. doi: 10.1016/j.ijrobp.2008.10.065
[7]
Xue J, Li X, Lu Y, Gan L, Zhou L, et al. (2013) Gene-modified mesenchymal stem cells protect against radiation-induced lung injury. Mol Ther 21: 456–465. doi: 10.1038/mt.2012.183
[8]
Martin M, Lefaix J, Delanian S (2000) TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target? Int J Radiat Oncol Biol Phys 47: 277–290. doi: 10.1016/s0360-3016(00)00435-1
[9]
Shah R, Hurley CK, Posch PE (2006) A molecular mechanism for the differential regulation of TGF-beta1 expression due to the common SNP -509C-T (c. -1347C>T). Hum Genet 120: 461–469. doi: 10.1007/s00439-006-0194-1
[10]
Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor beta in human disease. N Engl J Med 342: 1350–1358. doi: 10.1056/nejm200005043421807
[11]
Alsbeih G, Al-Harbi N, Al-Hadyan K, El-Sebaie M, Al-Rajhi N (2010) Association between normal tissue complications after radiotherapy and polymorphic variations in TGFB1 and XRCC1 genes. Radiat Res 173: 505–511. doi: 10.1667/rr1769.1
[12]
Niu X, Li H, Chen Z, Liu Y, Kan M, et al. (2012) A study of ethnic differences in TGFbeta1 gene polymorphisms and effects on the risk of radiation pneumonitis in non-small-cell lung cancer. J Thorac Oncol 7: 1668–1675. doi: 10.1097/jto.0b013e318267cf5b
[13]
Voets AM, Oberije C, Struijk RB, Reymen B, De Ruyck K, et al. (2012) No association between TGF-beta1 polymorphisms and radiation-induced lung toxicity in a European cohort of lung cancer patients. Radiother Oncol 105: 296–298. doi: 10.1016/j.radonc.2012.09.016
[14]
Wang L, Bi N (2010) TGF-beta1 gene polymorphisms for anticipating radiation-induced pneumonitis in non-small-cell lung cancer: different ethnic association. J Clin Oncol 28: e621–622. doi: 10.1200/jco.2010.31.0458
[15]
Yuan X, Liao Z, Liu Z, Wang LE, Tucker SL, et al. (2009) Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol 27: 3370–3378. doi: 10.1200/jco.2008.20.6763
[16]
Wang G (2011) Single nucleotide polymorphism of the TGFbeta 1 gene and its correlation to radiation pneumonitis in lung cancer patients. Available: http://cdmd.cnki.com.cn/Article/CDMD-104？40-1013125585.htm [Article in Chinese].
[17]
Zhang L (2008) Clinical and laboratory study on factors associated with radiation-induced-lung-injury and survival of lung cancer patients. Available: http://lib.cnki.net/cdmd/10023-200906362？1.html [Article in Chinese].
[18]
Andreassen CN, Alsner J, Overgaard J, Herskind C, Haviland J, et al. (2005) TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Radiother Oncol 75: 18–21. doi: 10.1016/j.radonc.2004.12.012
[19]
Zhao YC, Rees SE, Andreassen S, Kjaergaard S (2005) Simulation of pulmonary pathophysiology during spontaneous breathing. Conf Proc IEEE Eng Med Biol Soc 6: 6128–6131. doi: 10.1109/iembs.2005.1615892
